iBio (IBIO) Profit After Tax (2010 - 2026)

iBio (IBIO) has 17 years of Profit After Tax data on file, last reported at -$7.7 million in Q1 2026.

• On a quarterly basis, Profit After Tax fell 59.02% year-over-year to -$7.7 million in Q1 2026; TTM through Mar 2026 was -$27.6 million, a 31.51% decrease from a year earlier, with the FY2025 full-year figure at -$18.4 million, up 26.22% from the prior year.
• Profit After Tax for Q1 2026 stood at -$7.7 million, up from -$9.0 million in the prior quarter.
• Over the last five years, Profit After Tax for IBIO reached as high as -$3.2 million in Q1 2024 and fell as low as -$40.6 million in Q2 2023.
• Historically, Profit After Tax has averaged -$10.7 million across 5 years, with a median of -$6.7 million in 2022.
• Across the five-year window, Profit After Tax slumped 9211.4% in 2022 and jumped 80.86% in 2024, its largest moves.
• Year by year, Profit After Tax stood at -$33.6 million in 2022, then surged by 75.53% to -$8.2 million in 2023, then soared by 46.85% to -$4.4 million in 2024, then sank by 106.07% to -$9.0 million in 2025, then climbed by 14.04% to -$7.7 million in 2026.
• Per Business Quant data, the three most recent Profit After Tax figures were -$7.7 million in Q1 2026, -$9.0 million in Q4 2025, and -$5.7 million in Q3 2025.